3 hours Immuneering Co. (NASDAQ:IMRX) Receives Consensus Recommendation of “Moderate Buy” from BrokeragesMarketBeat
Shares of Immuneering Co. (NASDAQ:IMRX – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the seven brokerages that are presently covering the stock, Marketbeat Ratings reports. Three investment analysts have rated the st…
X